This finding is consistent with studies on human IBD tissue showing that TP53 mutations and loss of heterozygosity occur at a much higher frequency in IBD-CRC compared to sporadic CRC, and are an early event in IBD-driven carcinogenesis that can even be detected in non-dysplastic mucosa (75, 99, 100). This evidence concerns the gene TP53 and colorectal carcinoma.